Sareum Holdings and Genentech extend agreement
Under the terms of this agreement, Sareum will continue to apply its skills in high-throughput protein expression, purification and structure determination on drug discovery targets designated by Genentech.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.